MyoKardia, Inc. (MYOK): Debt Offering News

MYOK – Files mixed securities shelf offering.


Key Facts Surrounding This News Item


  • MYOK had a POWR Rating of B (Buy) coming into today.
  • MYOK was -6.08% below its 10-Day Moving Average coming into today.
  • MYOK was -0.94% below its 20-Day Moving Average coming into today.
  • MYOK was 6.86% above its 50-Day Moving Average coming into today.
  • MYOK was 23.36% above its 100-Day Moving Average coming into today.
  • MYOK was 53.01% above its 200-Day Moving Average coming into today.
  • MYOK had returned +30.64% year-to-date leading up to today’s news, versus a +2.22% return from the benchmark S&P 500 during the same period.

More Info About MyoKardia, Inc. (MYOK)


MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases View our full MYOK ticker page with ratings, news, and more.

MYOK at a Glance

MYOK Current POWR Rating™
Overall POWR Rating™
MYOK Current Price $53.26 3.50%
More MYOK Ratings, Data, and News

MYOK Price Reaction

The day of this event (Mar. 8, 2018)
MYOK Closing Price$54.15 1.55%
MYOK Volume434,700
15.61% from avg
Leading up to this event
MYOK 1-mo return14.46%
After this event
MYOK 1-day return3.68%
MYOK 3-day return10.33%
MYOK 5-day return8.91%

MYOK Price Chart


The Top Stocks For 2019

More MyoKardia, Inc. (MYOK) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MYOK News
Page generated in 0.9595 seconds.